New Alzheimer’s drug faces challenges
(By Alexandra Murphy for Becker’s Hospital Review) Leqembi, an Alzheimer’s drug from Biogen and Eisai, faces hurdles with respect to
Read More
Leqembi
New Alzheimer’s Drug Raises Hopes — Along With Questions
(By Judith Graham for KFF Health News) The FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer’s and
Read MoreWill the new Alzheimer’s drug put pressure on Medicare premiums?
The FDA approved the drug Leqembi, and Medicare will cover the new expensive new drug that promises the slowing the
Read More